Stockreport

Adaptimmune's SPEAR cells pass safety review in NSCLC study; dose to be raised; shares up 1% premarket [Seeking Alpha]

Adaptimmune Therapeutics plc - American Depositary Shares  (ADAP) 
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am Check Earnings Report
PDF Adaptimmune's SPEAR cells pass safety review in NSCLC study; dose to be raised; shares up 1% premarketAdaptimmune Therapeutics plc (NASDAQ:ADAP) is up1% premarket on lig [Read more]